Entering text into the input field will update the search result below

FDA clears Quidel molecular test for whooping cough

Jul. 16, 2018 1:13 PM ETQuidelOrtho Corporation (QDEL) StockBy: Douglas W. House, SA News Editor
  • The FDA grants 510(k) clearance for Quidel's (NASDAQ:QDEL -0.5%) Solana Bordetella Complete Assay, a qualitative molecular diagnostic test for pertussis (whooping cough) and parapertussis.
  • The company says the Solana instrument can process up to 12 samples per run.

Recommended For You

More Trending News

About QDEL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
QDEL--
QuidelOrtho Corporation